Login / Signup

Utilizing RNA and outlier analysis to identify an intronic splice-altering variant in AP4S1 in a sibling pair with progressive spastic paraplegia.

Carmel G McCulloughSzabolcs SzelingerNewell BelnapKeri RamseyIsabelle SchrauwenAna M ClaasenLeah W BurkeAshley L SiniardMatthew J HuentelmanVinodh NarayananDavid W Craig
Published in: Human mutation (2019)
We report a likely pathogenic splice-altering AP4S1 intronic variant in two sisters with progressive spastic paraplegia, global developmental delay, shy character, and foot deformities. Sequencing was completed on whole-blood messenger RNA (mRNA) and analyzed for gene expression outliers after exome sequencing analysis failed to identify a causative variant. AP4S1 was identified as an outlier and contained a rare homozygous variant located three bases upstream of exon 5 (NC_000014.8(NM_007077.4):c.295-3C>A). Confirmed by additional RNA-seq, reverse-transcription polymerase chain reaction, and Sanger sequencing, this variant corresponded with exon 5, including skipping, altered isoform usage, and loss of expression from the canonical isoform 2 (NM_001128126.3). Previously, loss-of-function variants within AP4S1 were associated with a quadriplegic cerebral palsy-6 phenotype, AP-4 Deficiency Syndrome. In this study, the inclusion of mRNA-seq allowed for the identification of a previously missed splice-altering variant, and thereby expands the mutational spectrum of AP-4 Deficiency Syndrome to include impacts to some tissue-dependent isoforms.
Keyphrases
  • single cell
  • transcription factor
  • cerebral palsy
  • rna seq
  • gene expression
  • multiple sclerosis
  • photodynamic therapy
  • copy number
  • dna methylation
  • binding protein
  • botulinum toxin